CLEOCIN T Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cleocin T, and what generic alternatives are available?
Cleocin T is a drug marketed by Pfizer and Pharmacia And Upjohn and is included in four NDAs.
The generic ingredient in CLEOCIN T is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cleocin T
A generic version of CLEOCIN T was approved as clindamycin phosphate by ALMAJECT on July 24th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLEOCIN T?
- What are the global sales for CLEOCIN T?
- What is Average Wholesale Price for CLEOCIN T?
Summary for CLEOCIN T
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 50 |
| Clinical Trials: | 11 |
| Patent Applications: | 2,341 |
| Drug Prices: | Drug price information for CLEOCIN T |
| What excipients (inactive ingredients) are in CLEOCIN T? | CLEOCIN T excipients list |
| DailyMed Link: | CLEOCIN T at DailyMed |
Recent Clinical Trials for CLEOCIN T
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Missouri-Columbia | Phase 4 |
| University of California, Los Angeles | Phase 4 |
| Roswell Park Cancer Institute | Phase 4 |
Pharmacology for CLEOCIN T
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
US Patents and Regulatory Information for CLEOCIN T
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | CLEOCIN T | clindamycin phosphate | GEL;TOPICAL | 050615-001 | Jan 7, 1987 | AB1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pharmacia And Upjohn | CLEOCIN T | clindamycin phosphate | SOLUTION;TOPICAL | 062363-001 | Feb 8, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | CLEOCIN T | clindamycin phosphate | LOTION;TOPICAL | 050600-001 | May 31, 1989 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | CLEOCIN T | clindamycin phosphate | SOLUTION;TOPICAL | 050537-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
